Psychosocial measures in relation to smartwatch alerts for atrial fibrillation detection

Cardiovasc Digit Health J. 2022 Aug 3;3(5):198-200. doi: 10.1016/j.cvdhj.2022.07.069. eCollection 2022 Oct.

Andreas Filippaios^{1

2}, Khanh-Van T Tran¹, Jordy Mehawej^{1

3}, Eric Ding³, Tenes Paul^{1

2}, Darleen Lessard³, Bruce Barton³, Honghuang Lin², Syed Naeem¹, Edith Mensah Otabil¹, Kamran Noorishirazi¹, Qiying Dai⁴, Hammad Sadiq¹, Ki H Chon⁵, Apurv Soni^{2

3}, Jane Saczynski⁶, David D McManus^{1

2

3}

¹ Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts.
² Program in Digital Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts.
³ Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, Massachusetts.
⁴ Division of Cardiovascular Medicine, Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts.
⁵ Department of Biomedical Engineering, University of Connecticut, Storrs, Connecticut.
⁶ Department of Pharmacy and Health Systems Sciences, School of Pharmacy, Northeastern University, Boston, Massachusetts.

No abstract available

Keywords: Alerts; Anxiety; Atrial fibrillation; Health-related quality of life; Patient activation; Randomized controlled trial; Smartwatches.

Grants and funding